Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke

2019; Massachusetts Medical Society; Volume: 382; Issue: 1 Linguagem: Inglês

10.1056/nejmoa1910355

ISSN

1533-4406

Autores

Pierre Amarenco, Kim Js, Julien Labreuche, Hubert Charles, Jérémy Abtan, Yannick Béjot, L. Cabrejo, Cha Jk, Grégory Ducrocq, Maurice Giroud, Céline Guidoux, Cristina Hobeanu, Kim Yj, Bertrand Lapergue, Philippa C. Lavallée, Lee Bc, Lee Kb, Didier Leys, Mahagne Mh, Elena Meseguer, Norbert Nighoghossian, Fernando Pico, Yves Samson, Igor Sibon, Philippe Gabríel Steg, Sung Sm, Pierre‐Jean Touboul, Emmanuel Touzé, Olivier Varenne, Éric Vicaut, Nessima Yelles, Éric Bruckert,

Tópico(s)

Acute Ischemic Stroke Management

Resumo

The use of intensive lipid-lowering therapy by means of statin medications is recommended after transient ischemic attack (TIA) and ischemic stroke of atherosclerotic origin. The target level for low-density lipoprotein (LDL) cholesterol to reduce cardiovascular events after stroke has not been well studied.

Referência(s)